Embed Size (px)
Citation preview
2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE
www.escardio.org/guidelines
Recommendation for cost-effective prevention of cardiovascular disease
5
www.escardio.org/guidelines
Impact of combinations of risk factors on risk
6
www.escardio.org/guidelines
Recommendations for cardiovascular risk assessment
7
www.escardio.org/guidelines
8
Recommendation for how to estimate cardiovascular risk
www.escardio.org/guidelines
9
Advantages and limitations in using the SCORE risk charts
www.escardio.org/guidelines
10
Examples of risk modifiers that are likely to have reclassification potential
www.escardio.org/guidelines
11
SCORE chart: 10-year risk of fatal cardiovascular disease in populations of countries at high cardiovascular risk based on the following riskfactors: age, sex, smoking, systolic blood pressure, total cholesterol.
www.escardio.org/guidelines
12
SCORE chart: 10-year risk of fatal cardiovascular disease in populations of countries at low cardiovascular risk based on the following riskfactors: age, sex, smoking, systolic blood pressure, total cholesterol.
www.escardio.org/guidelines
13
Relative risk chart, derived from SCORE Conversion of cholesterol mmol/Lmg/dL: 8 = 310; 7 = 270; 6 = 230; 5 = 190; 4 = 155.
www.escardio.org/guidelines
14
SCORE chart (for use in high-risk European countries) illustrating how the approximate risk age can be read off the chart.
www.escardio.org/guidelines
16
Risk factor goals & target levels for important CVD risk factors
www.escardio.org/guidelines
17
Risk factor goals & target levels for important CVD risk factors
www.escardio.org/guidelines
18
Recommendations for assessment of family history/(epi)genetics
www.escardio.org/guidelines
19
Recommendation for assessment of psychosocial riskfactors
www.escardio.org/guidelines
20
Core questions for the assessment ofpsychosocial risk factors in clinical practice
www.escardio.org/guidelines
21
Recommendation for assessment of circulating andurinary biomarkers
www.escardio.org/guidelines
22
Recommendations for imaging methods
www.escardio.org/guidelines
23
Recommendation for influenza vaccination
www.escardio.org/guidelines
24
Recommendations for patients treated for cancer
www.escardio.org/guidelines
25
Recommendations for autoimmune disease
www.escardio.org/guidelines
26
Recommendation for erectile dysfunction
www.escardio.org/guidelines
27
Recommendation for individuals <50 years of age
www.escardio.org/guidelines
28
Recommendations for female-specific conditions
www.escardio.org/guidelines
29
Recommendation for ethnic minorities
www.escardio.org/guidelines
30
Recommendations for facilitating changes in behaviour
www.escardio.org/guidelines
31
Principles of effective communication tofacilitate behaviouralchange
www.escardio.org/guidelines
32
Ten strategic steps to facilitate behaviour change
www.escardio.org/guidelines
33
Recommendations for psychosocial factors
www.escardio.org/guidelines
34
Recommendations for physical activity
www.escardio.org/guidelines
35
Classification of physical activity intensity and examples of absolute and relative intensity levels
www.escardio.org/guidelines
36
Recommendations for smoking intervention strategies
www.escardio.org/guidelines
37
The “Five As” for a smoking cessation strategy for routine practice
www.escardio.org/guidelines
42
Possible intervention strategies as a function of total cardiovascular risk & low-density lipoprotein cholesterol level
www.escardio.org/guidelines
44
Recommendations for management of diabetes (1)
www.escardio.org/guidelines
45
Recommendations for management of diabetes (2)
www.escardio.org/guidelines
46
Recommendations for management of hypertension (1)
www.escardio.org/guidelines
47
Recommendations for management of hypertension (2)
www.escardio.org/guidelines
48
Definition and classification of blood pressure levels
www.escardio.org/guidelines
49
Blood pressure thresholds for definition ofhypertension with different types of BP measurement
www.escardio.org/guidelines
50
Clinical indications for the use of out-of-officeblood pressure measurements
www.escardio.org/guidelines
51
Drugs to be preferred in specific conditions (1)
www.escardio.org/guidelines
52
Drugs to be preferred in specific conditions (2)
www.escardio.org/guidelines
53
Drugs to be preferred in specific conditions (3)
www.escardio.org/guidelines
54
Recommendations for antiplatelet therapy
www.escardio.org/guidelines
55
Recommendations for achieving medication adherence
www.escardio.org/guidelines
56
for population-based approaches to diet (1)
www.escardio.org/guidelines
57
Recommendations for population-based approaches to diet (2)
www.escardio.org/guidelines
58
for population-based approaches to physical activity
www.escardio.org/guidelines
59
for population-based approaches to physical activity
www.escardio.org/guidelines
60
Recommendations for population-based approaches to smoking and other tobacco use (1)
www.escardio.org/guidelines
61
Recommendations for population-based approaches to smoking and other tobacco use (2)
www.escardio.org/guidelines
62
Recommendations for population-based approaches to smoking and other tobacco use (3)
www.escardio.org/guidelines
63
Recommendations for protecting against alcohol abuse (1)
www.escardio.org/guidelines
64
Recommendations for protecting against alcohol abuse (2)
www.escardio.org/guidelines
65
Recommendation for cardiovascular disease preventionin primary care
www.escardio.org/guidelines
66
Recommendation for CVD prevention strategies in theacute hospital admission setting
www.escardio.org/guidelines
67
Recommendations for specialized preventionprogrammes
www.escardio.org/guidelines
68
Recommendation for monitoring preventive strategies
www.escardio.org/guidelines
69
Examples of performance measurements of CVD prevention
www.escardio.org/guidelines
70
To do & not to do messages from the Guidelines (1)
www.escardio.org/guidelines
71
To do & not to do messages from the Guidelines (2)
www.escardio.org/guidelines
72
To do & not to do messages from the Guidelines (3)
www.escardio.org/guidelines
73
To do & not to do messages from the Guidelines (4)
www.escardio.org/guidelines
European CVD Prevention in clinical Practice (2016)
Full text available now!
www.escardio.org/guidelines
European Heart Journal doi:10.1093/eurheartj/ehw106
www.escardio.org/guidelines
EUROPEAN CVD PREVENTION IN CLINICAL PRACTICE (2016)
The Pocket Guidelines will be available at the ESC Congress in Roma
www.escardio.org/guidelines
76
ESC Pocket Guidelines Application available in Roma!
www.escardio.org/guidelines
![Reducing Premature Cardiovascular Morbidity and Mortality ... › cvd...prevalent cardiovascular disease (CVD) worldwide is likely to be around 100 million[1e3].Thefive-year rate](https://img.dokumen.tips/doc/110x75/5f0e23587e708231d43dcb54/reducing-premature-cardiovascular-morbidity-and-mortality-a-cvd-prevalent.jpg)
